The pharma industry goal:
A world-wide
nicotine monopoly
There is no longer any doubt about the pharmaceutical intent of the attacks on tobacco: They want the world monopoly on nicotine. Therefore the corporations create long-term financial relationships with doctors, experts and anti-tobacco activists, who they believe can be used to achieve this goal.
The attack on tobacco dates back to the introduction of Nicorette in the 1980s, if not earlier. But it has been done partially hidden from the public due to the successful pharmaceutical strategy of parading “health” and clean white medical gowns in front of them in order to control the media.
The goal is no longer hidden however: When the TPSAC Committee was founded in 2010 with a total of four pharma-sponsored experts, GlaxoSmithKline immediately went to the FDA and
urged them to remove all tobacco industry smokeless products from the US market – including the Swedish snus. This probably led to the suit that the two tobacco companies filed against the FDA.
It is also clear that the pharmaceutical giants are puppet-masters of the opposition to another competing nicotine product: The harmless nicotine E-cigarette, which has been banned in many places, also in Denmark. The E-cigarette has been a threat to the pharmaceutical nicotine profits, since it succeeded in
taking half of the Nicorette market in 2012. It only made matters worse for the pharma corporations when the tobacco industry began to buy E-cigarette companies.
The most significant cause of these strange E-cigarette bans is the fact that the leading experts, who have called the authorities to ban E-cigarettes, in
many cases, have received generous donations from Pfizer, GlaxoSmithKline and other pharmaceutical companies in the nicotine market.
It was also Big Pharma’s very successful media and lobbying campaigns that led the EU Commission to make very restrictive rules for the sale of e-cigarettes, and to continue the senseless European ban on snus in the so-called EU
tobacco products directive.